New Treatments & Clinical Trials for Tinnitus

Tinnitus is the perception of sound — often ringing, buzzing, or hissing — when no external sound is present. It affects about 10-15% of adults, with roughly 2% experiencing severe, life-disrupting tinnitus. Current treatment focuses on managing distress through sound therapy, counseling, and hearing aids, since no FDA-approved drug targets tinnitus itself.

What's actually going on in research

Trials are testing drugs that modulate brain activity (including potassium channel openers and NMDA receptor antagonists), neuromodulation devices that pair sound with tongue or vagus nerve stimulation, and treatments for specific tinnitus causes like Meniere's disease. Researchers are also studying how tinnitus changes brain networks and whether targeting those networks can reduce perception of phantom sound.

What to know before you search

Eligibility often depends on tinnitus duration, severity, hearing loss status, whether a specific cause is identified, and absence of certain psychiatric or neurological conditions.

What types of trials are currently open

• Drug trials — Testing medications that act on the inner ear, auditory nerve, or brain circuits involved in tinnitus perception.
• Neuromodulation trials — Studies of devices that stimulate nerves while playing sounds, attempting to reset the brain's response to phantom noise.
• Behavioral trials — Testing forms of therapy — like cognitive behavioral therapy or mindfulness — that aim to reduce tinnitus distress even if the sound remains.
• Cause-specific trials — Treatments targeting underlying conditions such as Meniere's disease, middle ear muscle spasm, or temporomandibular joint disorder.
• Observational studies — Following people with tinnitus over time to understand which factors predict worsening or improvement and how brain activity changes.